2	O
.	O

Methods	O

We	O
conducted	O
a	O
systematic	O
study	O
of	O
patients	O
hospitalized	O
from	O
August	O
2006	O
until	O
September	O
2007	O
at	O
the	O
Yerevan	O
City	O
and	O
the	O
Republican	O
Dispensaries	O
,	O
the	O
two	O
reference	O
TB	O
hospitals	O
in	O
Armenia	O
.	O

Following	O
focus	O
group	O
discussions	O
and	O
pilot	O
testing	O
to	O
refine	O
the	O
survey	O
instrument	O
,	O
patient	O
interviews	O
began	O
in	O
the	O
fall	O
of	O
2006	O
and	O
were	O
conducted	O
by	O
trained	O
students	O
in	O
the	O
public	O
health	O
program	O
of	O
the	O
American	O
University	O
of	O
Armenia	O
.	O

Students	O
received	O
training	O
by	O
the	O
study	O
designer	O
(	O
SO	O
)	O
on	O
principles	O
of	O
interview	O
ethics	O
and	O
interviewing	O
processes	O
.	O

Most	O
patient	O
interviews	O
were	O
conducted	O
at	O
the	O
Republican	O
Dispensary	O
in	O
Abovian	O
Marz	O
,	O
the	O
national	O
TB	O
diagnostic	O
and	O
treatment	O
facility	O
to	O
which	O
all	O
suspected	O
cases	O
throughout	O
the	O
country	O
are	O
referred	O
for	O
diagnostic	O
confirmation	O
.	O

In	O
the	O
past	O
several	O
years	O
,	O
strong	O
financial	O
support	O
has	O
been	O
provided	O
to	O
Armenia	O
by	O
a	O
number	O
of	O
international	O
organizations	O
,	O
such	O
as	O
the	O
German	O
Gesellschaft	O
fur	O
Technische	O
Zusammenarbeit	O
(	O
GTZ	O
)	O
,	O
the	O
Global	O
Fund	O
to	O
Fight	O
AIDS	O
,	O
Tuberculosis	O
and	O
Malaria	O
,	O
and	O
the	O
Red	O
Cross	O
,	O
which	O
has	O
enabled	O
both	O
microscopic	O
and	O
culture	B-Cell
examinations	O
for	O
each	O
TB	O
case	O
to	O
be	O
performed	O
at	O
the	O
National	O
Reference	O
Laboratory	O
located	O
at	O
the	O
Republican	O
TB	O
Dispensary	O
.	O

All	O
culture	B-Cell
-	O
confirmed	O
TB	O
cases	O
are	O
admitted	O
as	O
in	O
-	O
patients	O
while	O
undergoing	O
the	O
initial	O
phase	O
of	O
therapy	O
.	O

Because	O
all	O
confirmed	O
TB	O
patients	O
in	O
Armenia	O
are	O
referred	O
to	O
one	O
of	O
these	O
dispensaries	O
for	O
treatment	O
,	O
this	O
population	O
represents	O
all	O
known	O
TB	O
cases	O
in	O
the	O
country	O
.	O

Therefore	O
,	O
all	O
culture	B-Cell
-	O
confirmed	O
TB	O
in	O
-	O
patients	O
present	O
at	O
the	O
time	O
of	O
the	O
interviewer	O
visits	O
were	O
eligible	O
for	O
inclusion	O
in	O
the	O
study	O
(	O
the	O
study	O
group	O
included	O
both	O
new	O
and	O
relapsed	O
patients	O
)	O
.	O

Our	O
systematic	O
sample	O
of	O
the	O
inpatient	O
TB	O
population	O
-	O
-	O
in	O
which	O
interviewers	O
visited	O
every	O
hospital	O
room	O
to	O
identify	O
patients	O
willing	O
to	O
participate	O
-	O
-	O
yielded	O
a	O
participation	O
rate	O
of	O
approximately	O
80	O
%	O
(	O
a	O
total	O
of	O
240	O
patients	O
)	O
.	O

Interviewers	O
collected	O
demographic	O
information	O
and	O
asked	O
each	O
patient	O
to	O
recall	O
when	O
they	O
first	O
began	O
to	O
feel	O
ill	O
,	O
what	O
symptoms	O
they	O
experienced	O
,	O
how	O
long	O
after	O
symptom	O
onset	O
they	O
waited	O
to	O
see	O
a	O
doctor	O
,	O
their	O
reasons	O
for	O
delaying	O
medical	O
evaluation	O
,	O
the	O
type	O
of	O
facility	O
at	O
which	O
they	O
first	O
sought	O
care	O
,	O
the	O
initial	O
diagnosis	O
,	O
if	O
they	O
had	O
been	O
referred	O
for	O
further	O
evaluation	O
,	O
and	O
their	O
adherence	O
to	O
treatment	O
once	O
diagnosed	O
with	O
TB	O
.	O

In	O
2006	O
,	O
129	O
of	O
the	O
planned	O
250	O
surveys	O
were	O
completed	O
.	O

Data	O
collection	O
resumed	O
in	O
the	O
fall	O
of	O
2007	O
and	O
a	O
total	O
of	O
240	O
interviews	O
were	O
conducted	O
.	O

